Pilot RCT in patients starting multimodality therapy for locally advanced rectal cancer: 20 of 34 eligible (59%) enrolled, just under the 60% target; 9 of 10 (90%) completed PATHWAYS (guide plus four coaching sessions) vs enhanced usual care, all finding it acceptable.
RCTn = 20
Lau-Min et al. Pilot Randomized Trial of a Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer